This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1t04

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1t04.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1t04.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1t04| PDB=1t04 | SCENE= }}
{{STRUCTURE_1t04| PDB=1t04 | SCENE= }}
-
'''Three dimensional structure of a humanized anti-IFN-Gamma Fab in C2 space group'''
+
===Three dimensional structure of a humanized anti-IFN-Gamma Fab in C2 space group===
-
==Overview==
+
<!--
-
Three-dimensional structures were determined for two crystal forms (orthorhombic P2(1)2(1)2(1) and monoclinic C2) of the Fab from the humanized version of a murine monoclonal antibody (AF2) that possesses binding and potent neutralizing activity against human interferon gamma (IFN-gamma). This humanized antibody (HuZAF; USAN name fontolizumab) is currently in phase II clinical trials for the treatment of Crohn's disease. HuZAF exhibits binding and IFN-gamma neutralizing capacities that closely approximate those of the original antibody. It is shown that HuZAF, whose VH domain was designed using a best-sequence-fit approach, is closer structurally to its mouse precursor than is a version whose VH was constructed using a human sequence with lower homology to the original mouse sequence. This work thus offers direct structural evidence in support of the best-sequence-fit approach and adds to previous results of biological and biochemical evaluations of distinctly engineered antibodies that also favored the use of a best-sequence-fit strategy. A second crystal type appeared during attempts to crystallize the Fab-IFN-gamma complex. The antibody-antigen complex that existed in solution dissociated in the crystallization mixture. A conformationally altered but unliganded HuZAF protein crystallized in a different space group (C2), with two Fab molecules in the asymmetric unit. In this crystal lattice, no space was available for accommodating the IFN-gamma antigen. Thus, there are currently three slightly different structures of the HuZAF Fab.
+
The line below this paragraph, {{ABSTRACT_PUBMED_15388922}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 15388922 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_15388922}}
==About this Structure==
==About this Structure==
Line 33: Line 37:
[[Category: Three-dimensional structure]]
[[Category: Three-dimensional structure]]
[[Category: X-ray structure]]
[[Category: X-ray structure]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 09:20:15 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 21:56:45 2008''

Revision as of 18:56, 28 July 2008

Image:1t04.png

Template:STRUCTURE 1t04

Three dimensional structure of a humanized anti-IFN-Gamma Fab in C2 space group

Template:ABSTRACT PUBMED 15388922

About this Structure

Full crystallographic information is available from OCA.

Reference

Three-dimensional structures of a humanized anti-IFN-gamma Fab (HuZAF) in two crystal forms., Bourne PC, Terzyan SS, Cloud G, Landolfi NF, Vasquez M, Edmundson AB, Acta Crystallogr D Biol Crystallogr. 2004 Oct;60(Pt 10):1761-9. Epub 2004, Sep 23. PMID:15388922

Page seeded by OCA on Mon Jul 28 21:56:45 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1t04"
Personal tools